VC-backed Cellerant Adds $16.7M
Cellerant Therapeutics Inc., a venture-backed biotech company, has sealed $16.7 million in government funding from the Biomedical Advanced Research and Development Authority in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services. The company, which has previously raised capital from Camelot Ventures and MPM Capital, is developing hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer.
15 September 2011•4 mins read
